stronger warnings about combining Enbrel (etanercept) and Kineret (anakinra)
February 2003
Amgen is now issuing stronger warnings about combining Enbrel (etanercept) and Kineret (anakinra).
Both Enbrel and Kineret are biologic agents for treating moderate to severe rheumatoid arthritis.
They both inhibit inflammation...but in a different way. Kineret selectively blocks interleukin-1...Enbrel blocks tumor necrosis factor.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive